VIVS
VivoSim Labs, Inc.
NASDAQ · Healthcare
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2014 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||
| Capital Expenditures | 13,000 | 42,000 | 396,000 | 409,000 | 405,000 | 0 | 79,000 | 226,000 | 277,000 | 357,000 | 46,000 | 48,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||
| Free Cash Flow | -9.5M | -14.7M | -12.8M | -8.9M | -13.7M | -14.9M | -20.5M | -29.1M | -15.8M | -10.1M | -2.0M | -868,000 |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — |